Sign in
4

Changes in Ownership

Fulcrum Therapeutics, Inc. Filed Acc 0000899243-21-003173

VP Finance & Accounting sold 6,607 shares at $14.00 ($92,498)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Thomson Peter G. VP Finance & Accounting 2021-01-21 Sale −6,607 $14.00 $92,498 15,212 D: show line 1 in the form
Open-market sales · 6,607 sh · avg $14.00 · $92,498
Loading xslF345X03/doc4.xml…